We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Top Buys

Rank Stock Value
1
PLAY icon
Dave & Buster's
PLAY
+$2.84M
2
LYV icon
Live Nation Entertainment
LYV
+$2.81M
3
WWW icon
Wolverine World Wide
WWW
+$2.72M
4
TSLA icon
Tesla
TSLA
+$2.63M
5
CALY
Callaway Golf Company
CALY
+$2.58M

Top Sells

Rank Stock Value
1
G icon
Genpact
G
+$3.61M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.99M
3
EXTR icon
Extreme Networks
EXTR
+$2.33M
4
CASY icon
Casey's General Stores
CASY
+$2.21M
5
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLO icon
201
Flowers Foods
FLO
$1.57B
$914K 0.12%
+37,032
New +$1M
IBP icon
202
Installed Building Products
IBP
$6.54B
$914K 0.12%
11,280
-916
-8% -$84.7K
RAPT
203
DELISTED
RAPT Therapeutics
RAPT
$912K 0.12%
4,736
+3,346
+241% +$633K
BCC icon
204
Boise Cascade
BCC
$3.03B
$907K 0.12%
+15,248
New +$981K
ITRI icon
205
Itron
ITRI
$4.52B
$907K 0.12%
+21,529
New +$1.07M
NKE icon
206
Nike
NKE
$62B
$906K 0.12%
+10,899
New +$1.17M
ABMD
207
DELISTED
Abiomed Inc
ABMD
$904K 0.12%
3,681
+1,714
+87% +$463K
KMT icon
208
Kennametal
KMT
$2.54B
$903K 0.12%
+43,883
New +$1.06M
UFPI icon
209
UFP Industries
UFPI
$5.19B
$901K 0.12%
+12,481
New +$993K
FIS icon
210
Fidelity National Information Services
FIS
$22.1B
$896K 0.12%
+11,861
New +$1.1M
WST icon
211
West Pharmaceutical
WST
$25B
$891K 0.12%
3,622
+87
+2% +$26.5K
PB icon
212
Prosperity Bancshares
PB
$8.87B
$889K 0.12%
+13,335
New +$953K
FBC
213
DELISTED
Flagstar Bancorp, Inc. New
FBC
$888K 0.12%
+26,583
New +$1.02M
BBSI icon
214
Barrett Business Services
BBSI
$810M
$886K 0.12%
45,452
+29,992
+194% +$599K
TEX icon
215
Terex
TEX
$7.78B
$880K 0.12%
29,606
+16,603
+128% +$543K
PRMW
216
DELISTED
Primo Water Corporation
PRMW
$879K 0.12%
70,071
-75,390
-52% -$1.01M
KNTE
217
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$876K 0.12%
73,277
+16,898
+30% +$221K
MSFT icon
218
Microsoft
MSFT
$3.72T
$873K 0.12%
+3,747
New +$989K
HCC icon
219
Warrior Met Coal
HCC
$4.84B
$872K 0.12%
30,665
+17,972
+142% +$553K
RCKT icon
220
Rocket Pharmaceuticals
RCKT
$391M
$871K 0.12%
54,582
+33,293
+156% +$520K
FUL icon
221
H.B. Fuller
FUL
$3.28B
$870K 0.12%
14,481
+7,435
+106% +$473K
LDOS icon
222
Leidos
LDOS
$17.2B
$868K 0.12%
+9,926
New +$970K
LGIH icon
223
LGI Homes
LGIH
$1.41B
$866K 0.11%
+10,648
New +$1.04M
HPE icon
224
Hewlett Packard
HPE
$69.9B
$865K 0.11%
+72,197
New +$981K
SLVM icon
225
Sylvamo
SLVM
$1.64B
$865K 0.11%
+25,508
New +$968K
7 8
9
10 11

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.